Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.1%

135 terminated/withdrawn out of 1488 trials

Success Rate

87.6%

+1.0% vs industry average

Late-Stage Pipeline

8%

120 trials in Phase 3/4

Results Transparency

30%

289 of 950 completed trials have results

Key Signals

243 recruiting289 with results101 terminated34 withdrawn

Enrollment Performance

Analytics

N/A
313(37.7%)
Phase 2
229(27.6%)
Phase 1
150(18.1%)
Phase 3
93(11.2%)
Phase 4
27(3.3%)
Early Phase 1
18(2.2%)
830Total
N/A(313)
Phase 2(229)
Phase 1(150)
Phase 3(93)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1488)

Showing 20 of 1488 trials
NCT07388550Phase 1Not Yet Recruiting

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Role: lead

NCT05047172Phase 3Active Not Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Role: collaborator

NCT01851447Active Not Recruiting

Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy

Role: collaborator

NCT01875588Recruiting

Thinking and Memory Problems in People With HIV

Role: lead

NCT04363684Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Role: collaborator

NCT01169259Phase 3Active Not Recruiting

Vitamin D and Omega-3 Trial (VITAL)

Role: collaborator

NCT01900132Not ApplicableRecruiting

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Role: lead

NCT07416188Phase 1Recruiting

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Role: lead

NCT07137442Recruiting

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

Role: lead

NCT06615973Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

Role: lead

NCT02522611Phase 1Not Yet Recruiting

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Role: lead

NCT06578195Recruiting

ASSESS ALL ALS Study

Role: collaborator

NCT07074678Not ApplicableEnrolling By Invitation

Prognostication of Recovery in Early Disorders of Consciousness Study

Role: collaborator

NCT01925196Completed

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

Role: lead

NCT06581861Recruiting

PREVENT ALL ALS Study

Role: collaborator

NCT02191488Phase 1Active Not Recruiting

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Role: collaborator

NCT03234478Completed

Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

Role: collaborator

NCT06623994Not ApplicableRecruiting

Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)

Role: collaborator

NCT02691923Phase 2Active Not Recruiting

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Role: collaborator

NCT01287156Completed

Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury

Role: collaborator